Home › Lupus Nephritis › Kansas
Lupus Nephritis clinical trials in Kansas
3 studies for Lupus Nephritis are looking for participants at sites in Kansas.
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Wichita Community Clcl Onco Program, Wichita
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Oct 1, 2026 · NCT05268289A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- University of Kansas Medical Center, Kansas City
RecruitingPhase 1
Ages 18 to 74 · All sexes · Updated Sep 10, 2026 · NCT07085104RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of Kansas Medical Center, Kansas City
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Aug 26, 2026 · NCT06121297From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.